UBS O'Connor’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

UBS O'Connor’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-381,797	Closed	-$3.86M	–	752
2022 Q3	$3.86M	Sell	381,797 -38,221	-9%	-$386K	0.04%	364
2022 Q2	$4.21M	Buy	+420,018	New	+$4.22M	0.04%	369

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UBS O'Connor's ARCK Position: Q4 2022 in Review

UBS O'Connor sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 381,797 shares — an estimated $3.86M sold.

UBS O'Connor first reported a position in ARCK in Q2 2022 and held it in 2 quarters. The position peaked at $4.21M in Q2 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

UBS O'Connor reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 381,797 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $3.86M.
UBS O'Connor first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q2 2022 and held it in 2 quarters.
UBS O'Connor's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $4.21M in Q2 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.